4processed
Form 4 — Insider Transaction
Telomir Pharmaceuticals, Inc.(TELO)
Filing Date
May 21, 2026
Accepted
May 21, 2026
Accession No.
0001493152-26-025116
CIK
0001971532
Insider Transactions
| Insider | Title | Type | Shares | Price | Value | Owned After | Security | Date |
|---|---|---|---|---|---|---|---|---|
| Aminov Erez | CEO and Chairman | Other | 1.96M | — | — | 1.96M | Incentive Stock Options (right to buy) | May 21, 2026 |
| Aminov Erez | CEO and Chairman | Other | 1.96M | — | — | 0 | Incentive Stock Options (right to buy) | May 21, 2026 |
| Aminov Erez | CEO and Chairman | Other | 2.00M | — | — | 2.00M | Non-Qualified Stock Options (right to buy) | May 21, 2026 |
| Aminov Erez | CEO and Chairman | Other | 2.00M | — | — | 0 | Non-Qualified Stock Options (right to buy) | May 21, 2026 |